PTSD Studies
Post-Traumatic Stress Disorder
Phase 2/3Active
Key Facts
Indication
Post-Traumatic Stress Disorder
Phase
Phase 2/3
Status
Active
About Pacific Clinical Research Medical Group
Pacific Clinical Research Medical Group is a long-established, private clinical research site organization that conducts Phase II-IV clinical trials for pharmaceutical sponsors, predominantly in psychiatry and neurology. Its business model is service-based, generating revenue by contracting with sponsors to recruit patients, administer trial protocols, and collect data. The company operates from a single physical site in Southern California and leverages its experienced medical team to attract trial participants by offering complementary care and medication. It occupies a niche as an investigative site within the broader clinical trial ecosystem.
View full company profileTherapeutic Areas
Other Post-Traumatic Stress Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| PTSD Program | Ignite Biomedical | Discovery |
| Intranasal SPC-15 for PTSD (with Silo Pharma) | Resyca | Preclinical/CMC Development |